Posts by Salvia Jain, MD
-
Optimizing Treatment Alternatives for Relapsed/Refractory T Cell Lymphomas
Massachusetts General Hospital leads the global PETAL consortium to advance the understanding and treatment of newly diagnosed and relapsed/refractory T cell lymphomas.
Biography
Dr. Jain earned her medical degree from Mahatma Gandhi Missions Medical College, Mumbai and Christian Medical College, Vellore. She completed a residency in Internal Medicine at Tufts Medical Center in Boston, followed by a fellowship in Hematology and Oncology at the New York University Langone’s Cancer Center and subspecialty fellowship in cellular therapy and stem cell transplantation at the Stanford Blood and Bone Marrow Transplant Program. Dr. Jain is board certified in Hematology and Medical Oncology. Dr. Jain's clinical interests are in lymphoid malignancies, including all non-Hodgkin lymphomas, with particular focus in T-cell lymphomas. Dr Jain leads an active translational and clinical research program in T-cell lymphomas centered around understanding myeloid biology in the laboratory, dissecting mechanisms of resistance to novel therapeutics in T-cell lymphomas, and clinical development of new therapies involving immune checkpoints and epigenetic modifiers. She is a member of the American Society of Hematology and the American Society of Clinical Oncology, and American Association for Cancer Research. Dr. Jain is the recipient of several federal and foundation young investigator and career development awards, author of numerous manuscripts and book chapters on lymphoma, and lectures.
